Cargando…
Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
We assessed a possible role for high-risk human papillomavirus (HPV) testing in the policy after treatment for cervical intraepithelial neoplasia (CIN) 2 or 3 (moderate to severe dysplasia). According to the Dutch guidelines follow-up after treatment consists of cervical cytology at 6, 12 and 24 mon...
Autores principales: | Nobbenhuis, M A E, Meijer, C J L M, Brule, A J C van den, Rozendaal, L, Voorhorst, F J, Risse, E K J, Verheijen, R H M, Helmerhorst, T J M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363818/ https://www.ncbi.nlm.nih.gov/pubmed/11259094 http://dx.doi.org/10.1054/bjoc.2000.1689 |
Ejemplares similares
-
High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum
por: Nobbenhuis, M A E, et al.
Publicado: (2002) -
A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings
por: Jacobs, M V, et al.
Publicado: (1999) -
HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears
por: Zielinski, G D, et al.
Publicado: (2001) -
HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM
por: Gosens, Karien C.M., et al.
Publicado: (2021) -
Cervical intraepithelial neoplasia 3, coinfected with HPV-16 and -18--case report.
por: Park, J. S., et al.
Publicado: (1993)